Home | Publications | Technology place holder
place holder place holder

Technology

Gene Expression Reagents Markets


Publication Date   April 2007
Publisher   TriMark Publications
Product Type   Report
Pages   113
ISBN Number   TMRGER07-0401
Product Code   TRI070
Ask a question about this product?

Price £990.00

approximately: $1,850 | €1,256

Summary


The area of gene expression reagents is one of the newest and most important sectors of pharmaceutical and bioscience research and development. The term gene expression reagents refers to chemicals that are used in gene expression experiments that are performed to determine whether a particular gene is expressed-i.e., present-and in some cases at what levels, in a biological sample. The purpose of this TriMark Publications report is to describe the specific segments of the global gene expression reagents market. Within this area, the study covers those segments that are highly active in terms of innovation and growth. Specifically, this review examines the markets for gene expression reagents and small lab equipment all the way up to highly automated platforms. Emphasis is on those companies that are actively developing and marketing gene expression reagents for genomics research in the academic sector and the pharmaceutical, bioscience industry. This study concentrates on the laboratory reagent market segment and the companion gene expression reagents sector in the U.S. and around the world that use materials for genetic research. Particular attention is paid to those areas of the gene expression reagents sector that are showing the greatest growth or the most innovation.

Content


  • 1. Overview
    • 1.1 Objectives of the Report
    • 1.2 Methodology
    • 1.3 Scope of the Report
    • 1.4 Executive Summary
  • 2. Gene Expression
    • 2.1 The Genomics Revolution
    • 2.2 Basic Principles of Gene Expression
      • 2.3.1 Quantitative Real-Time PCR (qRT-PCR)
      • 2.3.2 PCR Labeling Chemistries
      • 2.3.3 TaqMan Probes
      • 2.3.4 SYBR Green
    • 2.4 Microarray Technology
    • 2.5 Microarray Target Preparation and Hybridization
    • 2.6 RNA Sample Preparation and Assessment
  • 3. Gene Expression Reagents
    • 3.1 Kit Format vs. Home-Brew Assays
    • 3.2 Whole Product Solutions
    • 3.3 Emerging Technologies
  • 4. Market Environment
    • 4.1 Institutional and Government Budgeting
    • 4.2 Worldwide Investment in Genomics Technologies and Research
    • 4.3 Industry Consolidation and Acquisitions
  • 5. Market Drivers
    • 5.1 Improved Assay Performance
    • 5.2 Cost Effective Systems
    • 5.3 Automation
    • 5.4 Bioinformatics Solutions
  • 6. Worldwide Market for Gene Expression Reagents
    • 6.1 Life Science Research
    • 6.2 Drug Discovery and Development, Molecular Diagnostics
    • 6.3 Commercial Production
    • 6.4 Gene Expression Market Size
      • 6.4.1 Real-Time PCR Revenue
      • 6.4.2 Commercial Microarray Revenue
      • 6.4.3 RNA Sample Preparation Revenue
    • 6.5 Gene Expression Reagent Market by Region
    • 6.6 Users of Gene Expression Products
      • 6.6.1 Core Laboratories
      • 6.6.2 Consortia
      • 6.6.3 Pharmaceutical and Biotechnology Companies
    • 6.7 Affiliation
    • 6.8 Job Function and Decision Makers
  • 7. Key Applications
    • 7.1 BioMarker Identification and Pharmacogenomics
    • 7.2 Toxicogenomics
    • 7.3 Molecular Diagnostics
  • 8. Vendor and Product Selection
    • 8.1 Product Adoption
    • 8.2 Drivers for Product Switching
  • 9. Leading Vendors
  • 10. Marketing Strategies
    • 10.1 e-Marketing and e-Commerce
    • 10.2 Catalog
    • 10.3 On-Site Cabinet Programs
  • 11. Pricing Strategies
    • 11.1 Price Elasticity
    • 11.2 Strategies
  • 12. Distribution Channels
  • 13. Competitive Situation
  • 14. Opportunities
  • 15. Market Strategy Profiles, Leading and Selected Vendors
    • 15.1 Applied Biosystems
      • 15.1.1 Applera Corporation-Corporate History and Structure
      • 15.1.2 Molecular Biology Technology and Products
      • 15.1.3 Acquisitions, Partnerships and Collaborations, 2006
      • 15.1.4 Product Portfolio Summary
      • 15.1.5 Real-Time PCR/Genomics Products and Consumables
      • 15.1.6 Real-Time PCR/Genomics New Product Introductions, 2006
      • 15.1.7 End-Users
      • 15.1.8 Distribution Channels
      • 15.1.9 Competition-Gene Expression Products
      • 15.1.10 Competitive Analysis
      • 15.1.11 Business Model
    • 15.2 Affymetrix
      • 15.2.1 Corporate History and Structure
      • 15.2.2 Technology
      • 15.2.3 Partnerships and Collaborations
      • 15.2.4 Product Portfolio Summary
      • 15.2.5 Complementary Services
      • 15.2.6 New Product Introductions
      • 15.2.7 End-Users
      • 15.2.8 Distribution Channels
      • 15.2.9 Competition
      • 15.2.10 Competitive Analysis
      • 15.2.11 Business Model
    • 15.3 Invitrogen
      • 15.3.1 Corporate History and Structure
      • 15.3.2 Technology
      • 15.3.3 Acquisitions
      • 15.3.4 Partnerships and Collaborations
      • 15.3.5 Product Profile Summary
      • 15.3.6 Gene Expression Product Portfolio
      • 15.3.7 New Product Introductions
      • 15.3.8 End-Users
      • 15.3.9 Distribution Channels
      • 15.3.10 Competition
      • 15.3.11 Competitive Analysis
      • 15.3.12 Business Model
    • 15.4 Qiagen
      • 15.4.1 Corporate History and Structure
      • 15.4.2 Technology
      • 15.4.3 Acquisitions, Partnerships and Collaborations
      • 15.4.4 Collaborations and Partnerships
      • 15.4.5 Product Portfolio Summary
      • 15.4.6 Complementary Services
      • 15.4.7 New Product Introductions
      • 15.4.8 End-Users
      • 15.4.9 Distribution Channels
      • 15.4.10 Competition
      • 15.4.11 Competitive Analysis
      • 15.4.12 Business Model
    • 15.5 GE Healthcare (Formerly Amersham Biosciences)
      • 15.5.1 Corporate History and Structure
      • 15.5.2 Technology
      • 15.5.3 Product Portfolio Summary
      • 15.5.4 Complementary Services
      • 15.5.5 Genomics New Product Introductions
      • 15.5.6 Amersham Biosciences End-Users
      • 15.5.7 Distribution Channels
      • 15.5.8 Competition
      • 15.5.9 Competitive Analysis
      • 15.5.10 Business Model
    • 15.6 Stratagene
      • 15.6.1 Corporate History and Structure
      • 15.6.2 Technology
      • 15.6.3 Acquisitions, Collaborations, Alliances and Partnerships
      • 15.6.4 Product Portfolio Summary-Research Products Division
      • 15.6.5 New Product Introductions
      • 15.6.6 Complementary Services
      • 15.6.7 End-Users
      • 15.6.8 Distribution Channels
      • 15.6.9 Competition
      • 15.6.10 Competitive Analysis
      • 15.6.11 Business Model
  • Appendix I: Leading Vendor's Gene Expression Products
  • Appendix II: Gene Expression Product Groups
  • Appendix III: Companies Offering Gene Expression Products
  • List Of Figures
    • Figure 2.1: Gene Expression Process
    • Figure 2.2: qRT-PCR Workflow
    • Figure 2.3: Microarray Workflow
    • Figure 6.1: Gene Expression Market by Region
    • Figure 6.2: Researchers Using Gene Expression Technologies Worldwide, 2005
    • Figure 6.3: Distribution of Laboratory Workers by Organization in North America
    • Figure 6.4: Laboratory Job Function
    • Figure 6.5: Product Selection and Purchasing Decision Makers
  • List Of Tables
    • Table 5.1: Microarray Analysis Cost per Sample
    • Table 5.2: Cost of qRT-PCR Research Reagents and Systems
    • Table 6.1: Five-Year Forecast-Gene Expression Reagents, Instruments
    • Table 6.2: RNA Sample Preparation Revenue
    • Table 6.3: Forecasted Annual Revenue-qRT-PCR, 2005-2010
    • Table 6.4: Forecasted Annual Revenue-Commercial Microarrays, Reagents, Instruments, 2005-2010
    • Table 6.5: Forecasted Annual Revenue-Gene Expression Reagents, Instruments, 2005-2010
    • Table 6.6: Forecasted Annual Revenue-RNA Sample Preparation, 2005-2010
    • Table 6.7: Projected Revenue Growth of Microarrays and Related Products
    • Table 6.8: Major Players' Distribution of Revenue by Region, 2005
    • Table 6.9: Decision Makers Profile
    • Table 9.1: Major Vendors-Gene Expression Reagents and RNA Sample Preparation
    • Table 9.2: Vendors' Key Statistics, 2005
    • Table 9.3: Vendors' Technology and Products
    • Table 11.1: RNA Sample Preparation-Vendors Prices
    • Table 11.2: qPCR Kits-Vendor's Prices
    • Table 11.3: Reverse Transcriptase-Vendor's Prices
    • Table 12.1: Distribution Channels
    • Table 15.1: Applied Biosystems Revenue, 2005
    • Table 15.2: Affymetrix Revenue, 2005
    • Table 15.3: Invitrogen Revenue, 2005
    • Table 15.4: Qiagen Revenue, 2005
    • Table 15.5: GE Healthcare Revenue, 2005
    • Table 15.6: Stratagene Revenue, 2005